Cello Group plc (LON:CLL)‘s stock had its “buy” rating reissued by equities researchers at Peel Hunt in a report released on Wednesday. They presently have a GBX 130 ($1.58) target price on the stock. Peel Hunt’s price target would suggest a potential upside of 26.21% from the company’s current price.

A number of other research analysts have also recently issued reports on CLL. Cenkos Securities Ltd restated a “buy” rating on shares of Cello Group plc in a report on Wednesday, September 14th. N+1 Singer restated a “buy” rating and set a GBX 128 ($1.56) price objective (up previously from GBX 127 ($1.55)) on shares of Cello Group plc in a report on Tuesday, September 20th. Finally, FinnCap restated a “buy” rating and set a GBX 132 ($1.61) price objective on shares of Cello Group plc in a report on Tuesday, October 4th. Five equities research analysts have rated the stock with a buy rating, Cello Group plc has a consensus rating of “Buy” and an average target price of GBX 123.75 ($1.51).

Analyst Recommendations for Cello Group plc (LON:CLL)

Cello Group plc (LON:CLL) opened at 103.00 on Wednesday. The firm’s market cap is GBX 89.41 million. The stock’s 50 day moving average is GBX 106.32 and its 200 day moving average is GBX 99.64. Cello Group plc has a 52 week low of GBX 77.10 and a 52 week high of GBX 115.00.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/cello-group-plc-cll-earns-buy-rating-from-peel-hunt.html

The business also recently declared a dividend, which will be paid on Friday, November 4th. Shareholders of record on Thursday, October 6th will be paid a GBX 1 ($0.01) dividend. This represents a yield of 0.94%. The ex-dividend date of this dividend is Thursday, October 6th.

Cello Group plc Company Profile

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.

Receive News & Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related companies with MarketBeat.com's FREE daily email newsletter.